Literature DB >> 23588814

Classification and treatment of men with chronic prostatitis/chronic pelvic pain syndrome using the UPOINT system.

Daniel A Shoskes1, J Curtis Nickel.   

Abstract

Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a common condition; however, many of the traditional therapies used in clinical practice fail to show efficacy when subjected to large randomized placebo-controlled trials. This may be because CP/CPPS is a heterogeneous syndrome rather than a specific disease which would explain the failure of "one size fits all" therapy. In order to direct appropriate therapy, we have developed a six-point clinical phenotyping system to evaluate patients with chronic urologic pelvic pain. The clinical domains are urinary symptoms, psychosocial dysfunction, organ-specific findings, infection, neurologic/systemic, and tenderness of muscles, which produces the acronym UPOINT. Each domain is diagnosed clinically and is associated with specific therapies. This approach is simple and has proven effective in our hands for patients even after many years of failed therapies.

Entities:  

Mesh:

Year:  2013        PMID: 23588814     DOI: 10.1007/s00345-013-1075-6

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  30 in total

1.  Pregabalin for the treatment of men with chronic prostatitis/chronic pelvic pain syndrome: a randomized controlled trial.

Authors:  Michel A Pontari; John N Krieger; Mark S Litwin; Paige C White; Rodney U Anderson; Mary McNaughton-Collins; J Curtis Nickel; Daniel A Shoskes; Richard B Alexander; Michael O'Leary; Scott Zeitlin; Shannon Chuai; J Richard Landis; Liyi Cen; Kathleen J Propert; John W Kusek; Leroy M Nyberg; Anthony J Schaeffer
Journal:  Arch Intern Med       Date:  2010-09-27

2.  Catastrophizing and pain-contingent rest predict patient adjustment in men with chronic prostatitis/chronic pelvic pain syndrome.

Authors:  Dean A Tripp; J Curtis Nickel; Yanlin Wang; Mark S Litwin; Mary McNaughton-Collins; J Richard Landis; Richard B Alexander; Anthony J Schaeffer; Michael P O'Leary; Michel A Pontari; Jackson E Fowler; Leroy M Nyberg; John W Kusek
Journal:  J Pain       Date:  2006-10       Impact factor: 5.820

3.  Phenotypically directed multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study using UPOINT.

Authors:  Daniel A Shoskes; J Curtis Nickel; Michael W Kattan
Journal:  Urology       Date:  2010-04-03       Impact factor: 2.649

4.  Is a sexual dysfunction domain important for quality of life in men with urological chronic pelvic pain syndrome? Signs "UPOINT" to yes.

Authors:  Seth N P Davis; Yitzchak M Binik; Rhonda Amsel; Serge Carrier
Journal:  J Urol       Date:  2012-11-16       Impact factor: 7.450

5.  6-day intensive treatment protocol for refractory chronic prostatitis/chronic pelvic pain syndrome using myofascial release and paradoxical relaxation training.

Authors:  Rodney U Anderson; David Wise; Timothy Sawyer; Patricia Glowe; Elaine K Orenberg
Journal:  J Urol       Date:  2011-02-22       Impact factor: 7.450

Review 6.  Chronic prostatitis/chronic pelvic pain syndrome and pelvic floor spasm: can we diagnose and treat?

Authors:  Karin E Westesson; Daniel A Shoskes
Journal:  Curr Urol Rep       Date:  2010-07       Impact factor: 3.092

7.  Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial.

Authors:  Richard B Alexander; Kathleen J Propert; Anthony J Schaeffer; J Richard Landis; J Curtis Nickel; Michael P O'Leary; Michel A Pontari; Mary McNaughton-Collins; Daniel A Shoskes; Craig V Comiter; Nand S Datta; Jackson E Fowler; Robert B Nadler; Scott I Zeitlin; Jill S Knauss; Yanlin Wang; John W Kusek; Leroy M Nyberg; Mark S Litwin
Journal:  Ann Intern Med       Date:  2004-10-19       Impact factor: 25.391

8.  Use of the UPOINT chronic prostatitis/chronic pelvic pain syndrome classification in European patient cohorts: sexual function domain improves correlations.

Authors:  Vittorio Magri; Florian Wagenlehner; Gianpaolo Perletti; Sebastian Schneider; Emanuela Marras; Kurt G Naber; Wolfgang Weidner
Journal:  J Urol       Date:  2010-10-16       Impact factor: 7.450

9.  Levofloxacin for chronic prostatitis/chronic pelvic pain syndrome in men: a randomized placebo-controlled multicenter trial.

Authors:  J Curtis Nickel; Joe Downey; Janet Clark; Richard W Casey; Peter J Pommerville; Jack Barkin; Gary Steinhoff; Gerald Brock; Allan B Patrick; Stanley Flax; Bernard Goldfarb; Bruce W Palmer; Joseph Zadra
Journal:  Urology       Date:  2003-10       Impact factor: 2.649

10.  Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes.

Authors:  Mary P FitzGerald; Rodney U Anderson; Jeannette Potts; Christopher K Payne; Kenneth M Peters; J Quentin Clemens; Rhonda Kotarinos; Laura Fraser; Annemarie Cosby; Carole Fortman; Cynthia Neville; Suzanne Badillo; Lisa Odabachian; Andrea Sanfield; Betsy O'Dougherty; Rick Halle-Podell; Liyi Cen; Shannon Chuai; J Richard Landis; Keith Mickelberg; Ted Barrell; John W Kusek; Leroy M Nyberg
Journal:  J Urol       Date:  2009-06-17       Impact factor: 7.450

View more
  12 in total

1.  Understanding chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS).

Authors:  J Curtis Nickel
Journal:  World J Urol       Date:  2013-06-28       Impact factor: 4.226

2.  Immunostimulation in chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): a one-year prospective, double-blind, placebo-controlled study.

Authors:  Florian M E Wagenlehner; Stefania Ballarini; Kurt G Naber
Journal:  World J Urol       Date:  2014-01-31       Impact factor: 4.226

Review 3.  Management of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): the studies, the evidence, and the impact.

Authors:  J Curtis Nickel; Daniel A Shoskes; Florian M E Wagenlehner
Journal:  World J Urol       Date:  2013-04-09       Impact factor: 4.226

4.  Multimodal therapy for category III chronic prostatitis/chronic pelvic pain syndrome in UPOINTS phenotyped patients.

Authors:  Vittorio Magri; Emanuela Marras; Antonella Restelli; Florian M E Wagenlehner; Gianpaolo Perletti
Journal:  Exp Ther Med       Date:  2014-12-19       Impact factor: 2.447

5.  Feasibility of robotic radical prostatectomy for medication refractory chronic prostatitis/chronic pelvic pain syndrome: Initial results.

Authors:  Sameer Chopra; Raj Satkunasivam; Monish Aron
Journal:  Indian J Urol       Date:  2016 Jul-Sep

Review 6.  Chronic Pelvic Pain: Assessment, Evaluation, and Objectivation.

Authors:  Maria Beatrice Passavanti; Vincenzo Pota; Pasquale Sansone; Caterina Aurilio; Lorenzo De Nardis; Maria Caterina Pace
Journal:  Pain Res Treat       Date:  2017-11-20

7.  Comparative Efficacy of Oral Chinese Patent Medicine for Chronic Prostatitis/Chronic Pelvic Pain Syndrome With Sexual Dysfunction: A Bayesian Network Meta-Analysis of Randomized Controlled Trials.

Authors:  Yang Zhang; Hongzhao Ma; Tao Nan; Yongqiang Li; Wei Zheng; Zhihui Zhou; Xiaoyong Gong
Journal:  Front Pharmacol       Date:  2021-05-10       Impact factor: 5.810

8.  Erectile Dysfunction in Chronic Prostatitis/Chronic Pelvic Pain Syndrome: Outcomes from a Multi-Center Study and Risk Factor Analysis in a Single Center.

Authors:  Yadong Zhang; Tao Zheng; Xiang'an Tu; Xin Chen; Zhu Wang; Shengfu Chen; Qiyun Yang; Zi Wan; Dayu Han; Haipeng Xiao; Xiangzhou Sun; Chunhua Deng
Journal:  PLoS One       Date:  2016-04-27       Impact factor: 3.240

Review 9.  Male chronic pelvic pain: An update.

Authors:  Christopher P Smith
Journal:  Indian J Urol       Date:  2016 Jan-Mar

10.  Chronic prostatitis developing due to candida infection: A case diagnosed 20 years later and review of up-to-date literature.

Authors:  Aykut Demirci; Nurten Bozlak; Selçuk Turkel
Journal:  Urol Case Rep       Date:  2018-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.